New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 25, 2013
09:23 EDTQIHU, SIRI, UNXL, AA, DVA, CLDX, GA, OREX, FMS, JNY, CAMT, COCO, NXTMOn The Fly: Pre-market Movers
HIGHER: Alcoa (AA), up 3.5% after shares upgraded at Goldman... Orexigen (OREX), up 16% after announcing successful interim analysis of study of weight loss drug... DaVita (DVA), up 4%, Fresenius (FMS), up 7.4% and NxStage (NXTM), up 2.3% after final dialysis ruling that Piper Jaffray says is positive for the companies... Camtek (CAMT), up 29% after parent Priortech says no basis for rumor of tender offer... Giant Interactive (GA), up 12.5% after receiving proposal to be acquired for $11.75 per share... Sirius XM (SIRI), up 4.4% after positive mention in this weekend's Barron's magazine... Jones Group (JNY), up 2.6% after Reuters reports Sycamore in talks to buy the company. DOWN AFTER EARNINGS: Qihoo 360 (QIHU), down 3.4%. ALSO LOWER: Uni-Pixel (UNXL), down 17.5% after disclosing SEC subpoenas... Celldex (ClDX), down 10.5% after reporting data on ongoing exploratory Phase 2 study of rindopepimut... Corinthian Colleges (COCO), down 5% after probe from Consumer Financial Protection Bureau comes to light.
News For DVA;NXTM;FMS;AA;COCO;OREX;UNXL;CAMT;GA;SIRI;JNY;CLDX;QIHU From The Last 14 Days
Check below for free stories on DVA;NXTM;FMS;AA;COCO;OREX;UNXL;CAMT;GA;SIRI;JNY;CLDX;QIHU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 8, 2014
16:01 EDTAAApple Netflix Citigroup Tesla Banco Santander Alcoa
Subscribe for More Information
15:12 EDTAANotable companies reporting after market close
Subscribe for More Information
15:03 EDTAAAlcoa technical comments ahead of results
Subscribe for More Information
14:58 EDTDVADaVita entry into Pennsylvania market an important deal, says Wells Fargo
Subscribe for More Information
14:51 EDTDVADaVita HealthCare Partners, Independence Blue Cross announce joint venture
Subscribe for More Information
13:49 EDTAAAlcoa April weekly 13 straddle priced for 6.3% move into Q1
Subscribe for More Information
11:03 EDTOREXPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
09:35 EDTAAActive equity options trading on open
Subscribe for More Information
07:31 EDTAAFutures suggest lower open for broader market
Stock futures are pointing to a moderately lower open as the market will try to reverse its recent downward trend. Investors will receive little help throughout the day, as little economic data is slated to be released. The Nasdaq has led the market lower, as it has seen its biggest three day drop since November 2011. The unofficial kickoff of the earnings season will occur tonight, when Alcoa (AA) is scheduled to release its first quarter results.
06:56 EDTDVAFinal MA rule a positive for DaVita, says William Blair
Subscribe for More Information
April 7, 2014
16:08 EDTJNYJones Group holders approve merger with Sycamore Partners for $15 per share
The Jones Group announced that, at the special meeting, The Jones Group shareholders overwhelmingly voted to approve the agreement pursuant to which affiliates of Sycamore Partners will acquire The Jones Group for $15.00 per share in cash, or a total transaction value of approximately $2.2B. With today's approval of the proposals by The Jones Group shareholders, The Jones Group Inc. and Sycamore Partners have received all requisite approvals required to complete the transaction. The companies are committed to a seamless transition and expect to close the transaction promptly.
16:07 EDTJNYJones Group holders approve merger with Sycamore Partners for $15 per share
Subscribe for More Information
16:02 EDTCLDXCelldex says CDX-014 to enter clinical development
Celldex Therapeutics reported results of preclinical studies evaluating the anti-tumor activity of CDX-014 against a variety of cell lines. Based on the results, CDX-014 will enter clinical development. CDX-014 is an antibody drug conjugate that targets the protein TIM-1. "The data presented today confirm that CDX-014 effectively targets the tumor marker TIM-1 in vitro and elicits significant anti-tumor activity in key models. We are currently completing manufacturing and IND-enabling studies and anticipate that CDX-014 will enter Phase 1 clinical studies in renal cell carcinoma and potentially other TIM-1 expressing tumors in 2015," said Tibor Keler, senior VP and Chief Scientific Officer of Celldex.
14:57 EDTCAMTCamtek's Falcon systems capable of infringing on two claims of a Rudolph patent
Subscribe for More Information
13:53 EDTQIHUQihoo 360 Technology volatility increases as shares pull back to six-week low
Subscribe for More Information
12:38 EDTAAEarnings Preview: Alcoa shares near 52-week high ahead of Q1 report
Subscribe for More Information
10:00 EDTAAOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
07:59 EDTAAAlcoa April volatility elevated, shares near 32-month high into Q1
Alcoa April weekly call option implied volatility is at 65, April is at 44, May is 35, June and September is at 32; compared to its 26-week average of 32 according to Track Data, suggesting large near term price movement into its expected release of Q1 results after the market close on April 8.
06:28 EDTAAAlcoa upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank upgraded Alcoa to Hold citing its more positive view on aluminum premia due to a delay in LME inventory destocking. The firm raised its price target for shares to $10 from $7.50.
06:14 EDTAAAlcoa may see turnaround due to investment in aluminum cars, WSJ says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use